Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365457687> ?p ?o ?g. }
- W4365457687 endingPage "1331" @default.
- W4365457687 startingPage "1321" @default.
- W4365457687 abstract "We sought to determine the effects of three treatments on hemoglobin (Hb) levels in patients with chronic mountain sickness (CMS): 1) descent to lower altitude, 2) nocturnal O2 supply, 3) administration of acetazolamide. Nineteen patients with CMS living at an altitude of 3,940 ± 130 m participated in the study, which consisted of a 3-wk intervention phase and a 4-wk postintervention phase. Six patients spent 3 wk at an altitude of 1,050 m (low altitude group, LAG), six received supplemental oxygen for 12 h overnight (oxygen group, OXG), and seven received 250 mg of acetazolamide daily (acetazolamide group, ACZG). Hemoglobin mass (Hbmass) was determined using an adapted carbon monoxide (CO) rebreathing method before, weekly during, and 4 wk postintervention. Hbmass decreased by 245 ± 116 g (P < 0.01) in the LAG and by 100 ± 38 g in OXG, and 99 ± 64 g in ACZG (P < 0.05, each), respectively. In LAG, hemoglobin concentration ([Hb]) decreased by 2.1 ± 0.8 g/dL and hematocrit by 7.4 ± 2.9% (both P < 0.01), whereas OXG and ACZG only trended toward lower values. Erythropoietin concentration ([EPO]) decreased between 81 ± 12% and 73 ± 21% in LAG at low altitude (P < 0.01) and increased by 161 ± 118% 5 days after return (P < 0.01). In OXG and ACZG, the [EPO] decrease was ∼75% and ∼50%, respectively, during the intervention (P < 0.01). Descent to low altitude (from 3,940 m to 1,050 m) is a fast-acting measure for the treatment of excessive erythrocytosis in patients with CMS, reducing Hbmass by 16% within 3 wk. Nighttime oxygen supplementation and daily acetazolamide administration are also effective, but reduce Hbmass by only 6%.NEW & NOTEWORTHY To our knowledge, this is the first study examining the effect of three different treatments [descending to lower altitude (from 3,900 m to 1,050 m), nocturnal oxygen supply, and administration of acetazolamide] on changes in hemoglobin mass in patients experiencing chronic mountain sickness (CMS). We report that descent to low altitude is a fast-acting measure for the treatment of excessive erythrocytosis in patients with CMS, reducing Hbmass by 16% within 3 wk. Nighttime oxygen supplementation and daily acetazolamide administration are also effective, but reduce Hbmass by only 6%. In all three treatments, the underlying mechanism is a reduction in plasma erythropoietin concentration due to higher oxygen availability." @default.
- W4365457687 created "2023-04-15" @default.
- W4365457687 creator A5003594560 @default.
- W4365457687 creator A5008764810 @default.
- W4365457687 creator A5017340949 @default.
- W4365457687 creator A5061699065 @default.
- W4365457687 creator A5066470795 @default.
- W4365457687 creator A5074861030 @default.
- W4365457687 creator A5080203448 @default.
- W4365457687 creator A5080593049 @default.
- W4365457687 creator A5089808004 @default.
- W4365457687 date "2023-06-01" @default.
- W4365457687 modified "2023-09-27" @default.
- W4365457687 title "Possible strategies to reduce altitude-related excessive polycythemia" @default.
- W4365457687 cites W1485182547 @default.
- W4365457687 cites W1586962800 @default.
- W4365457687 cites W163271541 @default.
- W4365457687 cites W1861135022 @default.
- W4365457687 cites W189138837 @default.
- W4365457687 cites W1971969349 @default.
- W4365457687 cites W1988074226 @default.
- W4365457687 cites W1992115070 @default.
- W4365457687 cites W2014202729 @default.
- W4365457687 cites W2021011593 @default.
- W4365457687 cites W2026334890 @default.
- W4365457687 cites W2027933736 @default.
- W4365457687 cites W2032305338 @default.
- W4365457687 cites W2032790874 @default.
- W4365457687 cites W2034263761 @default.
- W4365457687 cites W2055369191 @default.
- W4365457687 cites W2058397330 @default.
- W4365457687 cites W2060131692 @default.
- W4365457687 cites W2064821892 @default.
- W4365457687 cites W2091107957 @default.
- W4365457687 cites W2106002321 @default.
- W4365457687 cites W2107985522 @default.
- W4365457687 cites W2110065044 @default.
- W4365457687 cites W2115367688 @default.
- W4365457687 cites W2133449347 @default.
- W4365457687 cites W2149564214 @default.
- W4365457687 cites W2164003699 @default.
- W4365457687 cites W2165372850 @default.
- W4365457687 cites W2169904073 @default.
- W4365457687 cites W2170862900 @default.
- W4365457687 cites W2178566748 @default.
- W4365457687 cites W2179112516 @default.
- W4365457687 cites W2203163997 @default.
- W4365457687 cites W2233774635 @default.
- W4365457687 cites W2342589009 @default.
- W4365457687 cites W2395707035 @default.
- W4365457687 cites W2399470175 @default.
- W4365457687 cites W2735218837 @default.
- W4365457687 cites W2940999850 @default.
- W4365457687 cites W2975347164 @default.
- W4365457687 cites W3038777213 @default.
- W4365457687 cites W3112612189 @default.
- W4365457687 cites W3137169539 @default.
- W4365457687 cites W3188006650 @default.
- W4365457687 cites W4200513804 @default.
- W4365457687 cites W4206456476 @default.
- W4365457687 cites W4229014969 @default.
- W4365457687 cites W4236955631 @default.
- W4365457687 cites W4285741444 @default.
- W4365457687 doi "https://doi.org/10.1152/japplphysiol.00076.2023" @default.
- W4365457687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37055035" @default.
- W4365457687 hasPublicationYear "2023" @default.
- W4365457687 type Work @default.
- W4365457687 citedByCount "0" @default.
- W4365457687 crossrefType "journal-article" @default.
- W4365457687 hasAuthorship W4365457687A5003594560 @default.
- W4365457687 hasAuthorship W4365457687A5008764810 @default.
- W4365457687 hasAuthorship W4365457687A5017340949 @default.
- W4365457687 hasAuthorship W4365457687A5061699065 @default.
- W4365457687 hasAuthorship W4365457687A5066470795 @default.
- W4365457687 hasAuthorship W4365457687A5074861030 @default.
- W4365457687 hasAuthorship W4365457687A5080203448 @default.
- W4365457687 hasAuthorship W4365457687A5080593049 @default.
- W4365457687 hasAuthorship W4365457687A5089808004 @default.
- W4365457687 hasConcept C105702510 @default.
- W4365457687 hasConcept C126322002 @default.
- W4365457687 hasConcept C134018914 @default.
- W4365457687 hasConcept C140793950 @default.
- W4365457687 hasConcept C2524010 @default.
- W4365457687 hasConcept C2777334680 @default.
- W4365457687 hasConcept C2777405951 @default.
- W4365457687 hasConcept C2778534260 @default.
- W4365457687 hasConcept C2778917026 @default.
- W4365457687 hasConcept C2780959883 @default.
- W4365457687 hasConcept C33923547 @default.
- W4365457687 hasConcept C42219234 @default.
- W4365457687 hasConcept C6350597 @default.
- W4365457687 hasConcept C71924100 @default.
- W4365457687 hasConcept C8240015 @default.
- W4365457687 hasConcept C86803240 @default.
- W4365457687 hasConceptScore W4365457687C105702510 @default.
- W4365457687 hasConceptScore W4365457687C126322002 @default.
- W4365457687 hasConceptScore W4365457687C134018914 @default.
- W4365457687 hasConceptScore W4365457687C140793950 @default.